How to Buy Autolus Therapeutics Stock
Autolus Therapeutics PLC
Autolus Therapeutics plc is a clinical-stage biopharmaceutical entity primarily focused on pioneering T-cell-based immunotherapies for various oncological conditions.
Autolus Therapeutics stock last closed at $1.88, down 4.08% from the previous day, and has increased 31.47% in one year. It has overperformed other stocks in the Biotechnology industry by 0.46 percentage points. Autolus Therapeutics stock is currently +60% from its 52-week low of $1.18, and -27.13% from its 52-week high of $2.58.
As of Sep 11, 2026, there are 266.16M shares of AUTL outstanding. The market value of AUTL is $500.39M. In the past 24 hours, 1.73M AUTL shares were traded.
How to Buy Autolus Therapeutics Stock
Not sure how to invest in Autolus Therapeutics stock? Here's how.
- Decide where to buy Autolus Therapeutics stock: You need to pick an online brokerage, but don't worry - we've sifted through dozens of stock brokerages and apps to help you figure out where to buy Autolus Therapeutics stock.
- Sign up for a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
- Deposit funds into your investment account: Pick your payment method and add your information.
- Research Autolus Therapeutics stock: The Autolus Therapeutics ticker symbol is AUTL. Is Autolus Therapeutics stock a good investment? Should you buy shares of AUTL? How do AUTL's underlying business fundamentals look? Do top analysts think Autolus Therapeutics is a good buy? Why has AUTL's stock price moved recently? (Hint: Our stock market research website can help you understand if AUTL is a good stock to buy).
- Place your AUTL purchase: Decide if you will purchase AUTL shares at the current market price or use a limit order to buy AUTL shares at a given price.
- Monitor your AUTL investment: Create a watchlist to important updates regarding your new investment in Autolus Therapeutics stock.
Step 1: Decide where to buy Autolus Therapeutics stock
You need a brokerage account to access the NASDAQ market and buy AUTL stock.
Our preferred brokerage: eToro
Based on our analysis, eToro is the best brokerage. Here's why:
- You can invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
- Access to world markets: From Tech to Energy, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading stock exchanges.
- Social investing: eToro boasts a community with more than 20 million users globally. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of shares by opening an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Sign up for a brokerage account
Now that you've selected your brokerage, it's time to fill out some personal details so you can invest in AUTL stock today.
How to Set Up a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal data to open a new brokerage account.
- Submit your details by pressing the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your investment account
Now that you've finished signing up on the stocks app, your next step is to transfer the money for your investment:
Watch this video walkthrough to see the process of depositing funds into your new investment account.
Step 4: Research Autolus Therapeutics stock
Once you have decided on the best place to buy Autolus Therapeutics stock, it's critical to analyze their stock prior to buying, so you truly understand the risk and upside.
Autolus Therapeutics stock data
AUTL Due Diligence Score
WallStreetZen was created to help part-time investors perform better fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on AUTL's stock page.
What is the fair value of AUTL stock?
You can use a variety of different financial metrics, analyses, models, and charts to gauge AUTL's true value.
Using relative valuations measures:
- AUTL may be overvalued based on its P/B ratio of 6.69x, relative to Biotechnology industry P/B ratio of 5.32x
You can do more valuation research on AUTL's stock here.
AUTL Financial Health Summary
Passed Health Checks:
- There are more short-term assets than short-term liabilities on the AUTL balance sheet.
Failed Health Checks:
- AUTL has a relatively high debt to equity ratio of 5.59.
- Total AUTL debt is higher than 5 years ago, relative to shareholder equity.
- There are more long-term liabilities than short-term assets on the AUTL balance sheet.
- AUTL has $203.13M in cash and short term investments. This is not enough to cover its annual cash burn of $232.73M.
- AUTL has cash burn of 232732000. It does not have sufficient cash and short-term investments to cover this.
- AUTL profit margin has gone up by 5.22 percentage points in the past year, but the company is still unprofitable.
Is it a good time to buy Autolus Therapeutics stock, according to Wall Street analysts?
Out of 3 Wall Street analysts who give recommendations on AUTL, the consensus analyst rating on AUTL is a Buy
Please note that analyst ratings are not stock recommendations, nor are they investment advice.
You can dive deeper into what analysts are projecting on the Autolus Therapeutics stock forecast page.
AUTL Technicals
AUTL Performance Numbers
Last year, AUTL revenue was $117.39M. During the past five year, AUTL's revenue has grown by 108.24% per year. This was faster than the Biotechnology industry average of 23.88%.
You can analyze AUTL's earnings and revenue performance here.
What are AUTL insiders up to?
In the last year, executives and large shareholders at AUTL have bought more shares than they have sold.
Cintia Piccina, CCO of AUTL, was the latest AUTL insider to sell. They sold $15,681.57 worth of AUTL shares on Sep 2, 2026.
Learn more about who owns AUTL shares here.
Can I get consistent income from AUTL stock?
No, Autolus Therapeutics doesn't provide an income stream by paying out dividends.
Get opinions from other investors
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other investors have to say.
Step 5: Place your AUTL purchase
There are two primary order types:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are generally the easiest way to buy. - Limit order: A limit order is an order to buy or sell a stock at a specific price (or better).
If you want to make sure you're buying or selling at a specific price limit, use a limit order.
Hit the Open button and eToro will execute the order.
If you want additional help investing in stocks on eToro, watch the how to video below:
Step 6: Monitor your AUTL investment
Now that you own some AUTL shares, you'll want to stay up-to-date on your new company.
Add AUTL to a watchlist to keep tabs on your AUTL stock.
AUTL Feed
How to Buy Stock in Autolus Therapeutics
To summarize, here are the 6 steps for buying Autolus Therapeutics stock:
- Decide where to buy Autolus Therapeutics stock
- Sign up for a brokerage account
- Deposit funds into your investment account
- Research Autolus Therapeutics stock
- Place your AUTL purchase
- Monitor your AUTL investment
If you require a brokerage account, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to keep tabs on your new investment in Autolus Therapeutics, add AUTL to your watchlist by clicking the button below.
More Stock Buying Guides You May Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.